Efficacy, Acceptability, and Tolerability of Antipsychotics in Treatment-Resistant Schizophrenia: A Network Meta-analysis.
about
Cognitive behavioural therapy for auditory hallucinations in schizophrenia: A review.Pharmacological guidelines for schizophrenia: a systematic review and comparison of recommendations for the first episode.Atypical antipsychotics: recent research findings and applications to clinical practice: Proceedings of a symposium presented at the 29th Annual European College of Neuropsychopharmacology Congress, 19 September 2016, Vienna, Austria.Treatment for Negative Symptoms in Schizophrenia: A Comprehensive Review.Clozapine combined with different antipsychotic drugs for treatment-resistant schizophrenia.Three-month paliperidone palmitate - a new treatment option for schizophrenia.Presynaptic Dopamine Synthesis Capacity in Schizophrenia and Striatal Blood Flow Change During Antipsychotic Treatment and Medication-Free Conditions.A Network Meta-Analysis of Non-Melanoma Skin Cancer (NMSC) Treatments: Efficacy and Safety Assessment.What Is the Place of Clozapine in the Treatment of Early Psychosis in Canada?Clozapine Treatment and Cannabis Use in Adolescents with Psychotic Disorders - A Retrospective Cohort Chart ReviewGuidelines for the Pharmacotherapy of Schizophrenia in Adults.Cardiovascular Disease in Clozapine-Treated Patients: Evidence, Mechanisms and Management.Evaluating the Effect of the Changes in FDA Guidelines for Clozapine Monitoring.Molecular Mechanisms of Antipsychotic Drug-Induced Diabetes.Clozapine in primary care.Clozapine and Gastrointestinal Hypomotility.The Glasgow antipsychotic side-effects scale for clozapine in inpatients and outpatients with schizophrenia or schizoaffective disorder.Effective and underprescribed: what about clozapine?Pharmacological treatments for alleviating agitation in dementia: A systematic review and network meta-analysis.Clozapine for Treatment-Resistant Schizophrenia: Still the Gold Standard?Inconclusive Evidence in Support of the Dopamine Hypothesis of Psychosis: Why Neurobiological Research Must Consider Medication Use, Adjust for Important Confounders, Choose Stringent Comparators, and Use Larger Samples.The acute efficacy of antipsychotics in schizophrenia: a review of recent meta-analysesClozapine as a first- or second-line treatment in schizophrenia: a systematic review and meta-analysis
P2860
Q36146634-CAD6730E-53A9-461F-BEBF-2D0697724CC4Q37576827-41BBF18C-68ED-4CAA-B045-0D9C19169246Q37698621-BD38039E-C6A7-49C8-862B-B6C424893276Q38647035-DAEBEDB2-940F-4829-971B-841B4DC1CC28Q38741061-8AD04CD9-7002-4BEA-9205-67504360D971Q38840088-E48C549B-E9B0-445A-B051-BB4D255E70A5Q38848472-72DB0153-CB62-4009-8848-DF14DF2B9D10Q38859587-2F54F7BE-C8AA-47E9-BA34-90EC56E492BEQ38867008-94F4FB71-5CD0-426A-A910-330D14D6D31CQ38885071-E7F61756-178B-4748-B00F-0CC537C5C748Q39432209-B6821D65-17BA-40F6-9EAE-7568E3DAEE3BQ40082921-E3117F88-DE2C-4E4B-A6EB-C32373EDD51CQ43258382-EC51122F-CDF4-4D7A-9B46-DBDC94281A18Q47165661-9DBFBCF3-A825-4C9F-BC48-B21EE1D0C71AQ47551390-34FE7EC4-0556-4568-9AB4-7E8B60EEA382Q47565362-68D1270B-39BA-4CBC-A268-6FCC7E8A7B4FQ47575822-66C45256-A224-47D2-B38A-7CA19F34A529Q49453720-0ADADCD1-27C4-45DF-BFC6-60A2E80E959FQ53279360-E1744C38-5309-4CDE-A227-386B336ACE97Q53748909-C1DA2AEE-1C3E-4467-8C7B-2CCFA95D553BQ55186763-5A1DC911-19B4-4D57-98C7-EA929BA32177Q57817726-44D79FEB-2C58-48F2-8041-83D9294BAFB6Q58738328-5DC9FC6D-2CFA-4600-909B-E168AF821467
P2860
Efficacy, Acceptability, and Tolerability of Antipsychotics in Treatment-Resistant Schizophrenia: A Network Meta-analysis.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Efficacy, Acceptability, and T ...... enia: A Network Meta-analysis.
@en
type
label
Efficacy, Acceptability, and T ...... enia: A Network Meta-analysis.
@en
prefLabel
Efficacy, Acceptability, and T ...... enia: A Network Meta-analysis.
@en
P2093
P50
P1433
P1476
Efficacy, Acceptability, and T ...... enia: A Network Meta-analysis.
@en
P2093
Adriani Nikolakopoulou
Bartosz Helfer
Myrsini Gianatsi
Myrto T Samara
Stefan Leucht
P304
P356
10.1001/JAMAPSYCHIATRY.2015.2955
P407
P577
2016-02-03T00:00:00Z